Trial Profile
A Phase II Study to Establish the Efficacy of Synthetic Human SecretiN in Human Acute Pancreatitis (SNAP) Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Secretin (Primary)
- Indications Pancreatitis
- Focus Therapeutic Use
- Acronyms SNAP
- Sponsors ChiRhoClin
- 08 Apr 2019 Status changed from not yet recruiting to recruiting.
- 01 Oct 2018 New trial record